Literature DB >> 22406864

Pseudolaric acid B-driven phosphorylation of c-Jun impairs its role in stabilizing HIF-1alpha: a novel function-converter model.

Bing Yu1, Mei-Hong Li, Wei Wang, Ying-Qing Wang, Yi Jiang, Sheng-Ping Yang, Jian-Min Yue, Jian Ding, Ze-Hong Miao.   

Abstract

We have recently discovered that c-Jun executes a non-transcriptional function to stabilize hypoxia inducible factor 1α (HIF-1α) and that pseudolaric acid B (PAB) accelerates HIF-1α degradation and phosphorylates c-Jun at Ser63/73. In this study, PAB was used as a probe to investigate whether and how the Ser63/73 phosphorylation of c-Jun regulates its functions. The PAB-induced reduction of HIF-1α protein was rescued through supplying additional non-phosphorylated c-Jun. However, c-Jun siRNA, which reduced both the PAB-driven phosphorylated c-Jun and the total c-Jun protein, did not prevent the PAB-induced decrease in HIF-1α. HIF-1α was revealed to be co-immunoprecipitated only with the non-phosphorylated c-Jun. PAB increased the phosphorylated c-Jun while reducing the non-phosphorylated c-Jun at Ser63/73, which impaired its function in stabilizing HIF-1α. Consequently, PAB led to the degradation of HIF-1α, thus resulting in the decreased HIF-1α-dependent expression of mdr-1 and VEGF. We accordingly propose a function-converter model of c-Jun: the Ser63/73 phosphorylation serves as a function converter to convert c-Jun from its non-transcriptional function to its transcriptional function.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22406864     DOI: 10.1007/s00109-012-0865-4

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  35 in total

Review 1.  AP-1: a double-edged sword in tumorigenesis.

Authors:  Robert Eferl; Erwin F Wagner
Journal:  Nat Rev Cancer       Date:  2003-11       Impact factor: 60.716

2.  Pseudolaric acid B, a novel microtubule-destabilizing agent that circumvents multidrug resistance phenotype and exhibits antitumor activity in vivo.

Authors:  Vincent K W Wong; Pauline Chiu; Stephen S M Chung; Larry M C Chow; Yun-Zhe Zhao; Burton B Yang; Ben C B Ko
Journal:  Clin Cancer Res       Date:  2005-08-15       Impact factor: 12.531

Review 3.  AP-1 as a regulator of cell life and death.

Authors:  Eitan Shaulian; Michael Karin
Journal:  Nat Cell Biol       Date:  2002-05       Impact factor: 28.824

4.  Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation.

Authors:  A Behrens; M Sibilia; E F Wagner
Journal:  Nat Genet       Date:  1999-03       Impact factor: 38.330

5.  Total synthesis of (-)-pseudolaric acid B.

Authors:  Barry M Trost; Jerome Waser; Arndt Meyer
Journal:  J Am Chem Soc       Date:  2007-11-07       Impact factor: 15.419

6.  Survival of cancer cells is maintained by EGFR independent of its kinase activity.

Authors:  Zhang Weihua; Rachel Tsan; Wei-Chien Huang; Qiuyu Wu; Chao-Hua Chiu; Isaiah J Fidler; Mien-Chie Hung
Journal:  Cancer Cell       Date:  2008-05       Impact factor: 31.743

7.  A reinvestigation of the multisite phosphorylation of the transcription factor c-Jun.

Authors:  Simon Morton; Roger J Davis; Ann McLaren; Philip Cohen
Journal:  EMBO J       Date:  2003-08-01       Impact factor: 11.598

8.  Structural modification of an angiogenesis inhibitor discovered from traditional Chinese medicine and a structure-activity relationship study.

Authors:  Sheng-Ping Yang; Yu-Jun Cai; Bang-Le Zhang; Lin-Jiang Tong; Hua Xie; Yan Wu; Li-Ping Lin; Jian Ding; Jian-Min Yue
Journal:  J Med Chem       Date:  2007-12-14       Impact factor: 7.446

Review 9.  The von Hippel-Lindau tumour suppressor protein: O2 sensing and cancer.

Authors:  William G Kaelin
Journal:  Nat Rev Cancer       Date:  2008-10-16       Impact factor: 60.716

10.  Functions of c-Jun in liver and heart development.

Authors:  R Eferl; M Sibilia; F Hilberg; A Fuchsbichler; I Kufferath; B Guertl; R Zenz; E F Wagner; K Zatloukal
Journal:  J Cell Biol       Date:  1999-05-31       Impact factor: 10.539

View more
  9 in total

1.  Hypoxia induces universal but differential drug resistance and impairs anticancer mechanisms of 5-fluorouracil in hepatoma cells.

Authors:  Jing-Qiu Li; Xian Wu; Lu Gan; Xiang-Liang Yang; Ze-Hong Miao
Journal:  Acta Pharmacol Sin       Date:  2017-07-10       Impact factor: 6.150

2.  A compendium of proteins that interact with HIF-1α.

Authors:  Gregg L Semenza
Journal:  Exp Cell Res       Date:  2017-03-20       Impact factor: 3.905

Review 3.  Newly discovered angiogenesis inhibitors and their mechanisms of action.

Authors:  Ze-hong Miao; Jian-ming Feng; Jian Ding
Journal:  Acta Pharmacol Sin       Date:  2012-08-27       Impact factor: 6.150

Review 4.  Hypoxia inducible factor down-regulation, cancer and cancer stem cells (CSCs): ongoing success stories.

Authors:  Anthony R Martin; Cyril Ronco; Luc Demange; Rachid Benhida
Journal:  Medchemcomm       Date:  2016-10-19       Impact factor: 3.597

5.  Tanshinone I inhibits tumor angiogenesis by reducing Stat3 phosphorylation at Tyr705 and hypoxia-induced HIF-1α accumulation in both endothelial and tumor cells.

Authors:  Yan Wang; Jia-Xin Li; Ying-Qing Wang; Ze-Hong Miao
Journal:  Oncotarget       Date:  2015-06-30

6.  Tanshinone-1 induces tumor cell killing, enhanced by inhibition of secondary activation of signaling networks.

Authors:  L Xu; J-M Feng; J-X Li; J-M Zhu; S-S Song; L-J Tong; Y Chen; X-Y Yang; Y-Y Shen; F-L Lian; Y-P Li; D-H Lin; J Ding; Z-H Miao
Journal:  Cell Death Dis       Date:  2013-11-07       Impact factor: 8.469

Review 7.  A Systematic Review of the Immune-Regulating and Anticancer Activities of Pseudolaric Acid B.

Authors:  Mei-Lun Liu; Dan Sun; Tan Li; Hong Chen
Journal:  Front Pharmacol       Date:  2017-06-28       Impact factor: 5.810

Review 8.  Natural Products in Cancer Therapy: Past, Present and Future.

Authors:  Min Huang; Jin-Jian Lu; Jian Ding
Journal:  Nat Prod Bioprospect       Date:  2021-01-03

Review 9.  Targeting HIF-1α by Natural and Synthetic Compounds: A Promising Approach for Anti-Cancer Therapeutics Development.

Authors:  Rituparna Ghosh; Priya Samanta; Rupali Sarkar; Souradeep Biswas; Prosenjit Saha; Subhadip Hajra; Arijit Bhowmik
Journal:  Molecules       Date:  2022-08-15       Impact factor: 4.927

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.